Literature DB >> 19939836

Sepsis and the heart.

J D Hunter1, M Doddi.   

Abstract

Septic shock, the most severe complication of sepsis, accounts for approximately 10% of all admissions to intensive care. Our understanding of its complex pathophysiology remains incomplete but clearly involves stimulation of the immune system with subsequent inflammation and microvascular dysfunction. Cardiovascular dysfunction is pronounced and characterized by elements of hypovolaemic, cytotoxic, and distributive shock. In addition, significant myocardial depression is commonly observed. This septic cardiomyopathy is characterized by biventricular impairment of intrinsic myocardial contractility, with a subsequent reduction in left ventricular (LV) ejection fraction and LV stroke work index. This review details the myocardial dysfunction observed in adult septic shock, and discusses the underlying pathophysiology. The utility of using the regulatory protein troponin for the detection of myocardial dysfunction is also considered. Finally, options for the management of sepsis-induced LV hypokinesia are discussed, including the use of levosimendan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19939836     DOI: 10.1093/bja/aep339

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  70 in total

1.  When sepsis affects the heart: A case report and literature review.

Authors:  Giuseppe Clemente; Antonino Tuttolomondo; Daniela Colomba; Rosaria Pecoraro; Chiara Renda; Vittoriano Della Corte; Carlo Maida; Irene Simonetta; Antonio Pinto
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

2.  Prognosis of left ventricular systolic dysfunction in septic shock patients.

Authors:  M Mukhyaprana Prabhu; Suresh Kumar Yalakala; Ranjan Shetty; Ashok Thakkar; Tulsee Sitapara
Journal:  J Clin Diagn Res       Date:  2015-03-01

3.  A case of human immunodeficiency virus-related heart failure resembling dilated cardiomyopathy but accompanied by high cardiac output.

Authors:  Noriaki Tabata; Megumi Yamamuro; Seigo Sugiyama; Michio Mizobe; Seiji Takashio; Kenichi Tsujita; Eiichiro Yamamoto; Tomoko Tanaka; Sunao Kojima; Koichi Kaikita; Shinji Tayama; Seiji Hokimoto; Chiharu Syudo; Toshikazu Miyakawa; Hiroaki Mitsuya; Hisao Ogawa
Journal:  J Cardiol Cases       Date:  2014-08-26

4.  Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling network.

Authors:  Ian G Cannell; Michael B Yaffe
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

5.  [Levosimendan-no effect on multiorgan failure in septic shock].

Authors:  U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-20       Impact factor: 0.840

6.  Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism.

Authors:  Li Jianhui; Nathalie Rosenblatt-Velin; Noureddine Loukili; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-04       Impact factor: 4.733

Review 7.  Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation.

Authors:  Jeroen J H Bunge; Kadir Caliskan; Diederik Gommers; Dinis Reis Miranda
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 8.  Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms.

Authors:  Anthony Flynn; Bhalaghuru Chokkalingam Mani; Paul J Mather
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

9.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

10.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis.

Authors:  Osamu Takasu; Joseph P Gaut; Eizo Watanabe; Kathleen To; R Eliot Fagley; Brian Sato; Steve Jarman; Igor R Efimov; Deborah L Janks; Anil Srivastava; Sam B Bhayani; Anne Drewry; Paul E Swanson; Richard S Hotchkiss
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.